Table of Content


1 Report Overview
1.1 Global Human Microbiome Therapeutics Market Overview
1.2 Study Goals and Objectives
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.1 Key Questions Answered by This Analytical Report Include:
1.2 Who is This Report For?
1.3 Methodology
1.4.1 Primary Research
1.4.2 Secondary Research
1.4.3 Data Sources
1.4 Market Evaluation & Forecasting Methodology
1.5 COIVD-19 Impact Recovery Pattern Analysis
1.4.4 V-Shaped Recovery
1.4.5 U-Shaped Recovery
1.4.6 W-Shaped Recovery
1.4.7 L-Shaped Recovery
1.6 Frequently Asked Questions (FAQ)

2 Executive Summary
2.1 Key Take Away

3 Human Microbiome Therapeutics Products and Technology Overview
3.1 Introduction to Human Microbiome Therapeutics Products
3.1.1 The Human Microbiome
3.1.2 Gut Microbiome
3.1.3 Oral Microbiome
3.1.4 Skin Microbiome
3.2 Microbiome and Human Health and Disease
3.3 Essential Functions of Human Microbiome
3.4 Technologies Aiding Microbiome Research
3.5 Culturing and Cultivation
3.5.1 Animal Models
3.5.2 Gnotobiotic Animal Models
3.5.3 Engineered Systems
3.5.4 Organoid Cultures
3.5.5 Bioreactors
3.5.6 Microbiome Assaying
3.5.7 Direct Observation
3.5.8 Data Analysis
3.6 Microbiome Therapeutics Disease Areas
3.7 Regulatory Landscape for Microbiome Therapeutics
3.8 Microbiome Research Projects

4 Development of Microbiome Therapeutics
4.1 Additive Microbiome Therapy
4.2 Live Biotherapeutic Products (LBPs)
4.3 Modulatory Microbiome Therapy
4.3.1 Small Molecule Postbiotics
4.3.2 Prebiotics
4.4 Subtractive Microbiome Therapeutics
4.5 Antimicrobial Therapy
4.6 Phage Therapy

5 Market Dynamics
5.1 Overview
5.2 SWOT Analysis
5.3 Drivers of Microbiome Therapeutics Market
5.3.1 High Unmet Medical Need
5.3.2 Growing Understanding of the Microbiome
5.3.3 Positive Investment Environment
5.3.4 Strong Pipeline
5.3.5 Acceptance from Regulatory Authorities
5.4 Challenges for Microbiome Therapeutics Market
5.4.1 Lack of Regulatory Guidance
5.4.2 Product Characterization and Manufacturing Challenges
5.4.3 Hurdles in Preclinical and Clinical Research
5.4.4 Need for Skilled Labor
5.4.5 Emerging Markets
5.4.6 Development of Better Diagnostic Methods
5.4.7 Acquisitions and Partnerships
5.5 Threats to the Microbiome Therapeutics Market
5.5.1 New Government Regulations
5.5.2 Stiff Competition in the Global Market
5.5.3 COVID-19 Pandemic

6 Global Human Microbiome Therapeutics Market
6.1 Global Market Overview
6.2 Global Market Outlook in terms of Value (COVID-19 Impact Recovery Analysis)
6.3 Global Market Outlook by Region (COVID-19 Impact Recovery Analysis)
6.4 Global Market Outlook by Technology
6.4.1 Human Microbiome Therapeutics Technology Overview
6.4.2 Global Human Microbiome Therapeutics Market by Technology (Pre-COVID-19 Analysis)
6.4.3 Global Human Microbiome Therapeutics Market by Technology (Post-COVID-19 Impact Recovery Analysis)
6.5 Global Market Outlook by Therapeutics Areas (COVID-19 Impact Recovery Analysis)
6.6 Global Market Outlook by Type
6.6.1 Fecal Microbiota Transplants (FMTs)
6.6.2 Live Biotherapeutic Products (LBPs)
6.6.3 Monoclonal Microbials
6.6.4 Engineered Bacteria
6.6.5 Modulatory Microbiome Therapeutics
6.6.6 Subtractive Microbiome Therapeutics
6.6.7 Global Market Outlook by Type (Pre-COVID-19 Analysis)
6.6.8 Global Market Outlook by Type (Post-COVID-19 Impact Recovery Analysis)
6.7 Global Market Outlook by Product (COVID-19 Impact Recovery Analysis)

7 North America Human Microbiome Therapeutics Market
7.1 North America Market Overview
7.2 North America Market Outlook by Value (COVID-19 Impact Recovery Analysis)
7.3 North America Market Outlook by Country (COVID-19 Impact Recovery Analysis)
7.4 US Market Outlook
7.4.1 US Market Outlook by Value (COVID-19 Impact Recovery Analysis)
7.5 Canada Market Outlook
7.5.1 Canada Market Outlook by Value (COVID-19 Impact Recovery Analysis)
7.6 North America Market Outlook by Technology (COVID-19 Impact Recovery Analysis)
7.7 North America Market Outlook by Therapeutics Areas (COVID-19 Impact Recovery Analysis)
7.8 North America Market Outlook by Type (COVID-19 Impact Recovery Analysis)
7.9 North America Market Outlook by Product (COVID-19 Impact Recovery Analysis)

8 Europe Human Microbiome Therapeutics Market
8.1 Europe Market Overview
8.2 Europe Market Outlook by Value (COVID-19 Impact Recovery Analysis)
8.3 Europe Market Outlook by Country (COVID-19 Impact Recovery Analysis)
8.4 Russia Market Outlook
8.4.1 Russia Market Outlook by Value (COVID-19 Impact Recovery Analysis)
8.5 Germany Market Outlook
8.5.1 Germany Market Outlook by Value (COVID-19 Impact Recovery Analysis)
8.6 UK Market Outlook
8.6.1 UK Market Outlook by Value (COVID-19 Impact Recovery Analysis)
8.7 France Market Outlook
8.7.1 France Market Outlook by Value (COVID-19 Impact Recovery Analysis)
8.8 Italy Market Outlook
8.8.1 Italy Market Outlook by Value (COVID-19 Impact Recovery Analysis)
8.9 Rest of Europe Market Outlook
8.9.1 Rest of Europe Market Outlook by Value (COVID-19 Impact Recovery Analysis)
8.10 Europe Market Outlook by Technology (COVID-19 Impact Recovery Analysis)
8.11 Europe Market Outlook by Therapeutics Areas (COVID-19 Impact Recovery Analysis)
8.12 Europe Market Outlook by Type (COVID-19 Impact Recovery Analysis)
8.13 Europe Market Outlook by Product (COVID-19 Impact Recovery Analysis)

9 Asia-Pacific Human Microbiome Therapeutics Market
9.1 Asia-Pacific Market Overview
9.2 Asia-Pacific Market Outlook by Value (COVID-19 Impact Recovery Analysis)
9.3 Asia-Pacific Market Outlook by Country (COVID-19 Impact Recovery Analysis)
9.4 Japan Market Outlook
9.4.1 Japan Market Outlook by Value (COVID-19 Impact Recovery Analysis)
9.5 China Market Outlook
9.5.1 China Market Outlook by Value (COVID-19 Impact Recovery Analysis)
9.6 India Market Outlook
9.6.1 India Market Outlook by Value (COVID-19 Impact Recovery Analysis)
9.7 South Korea Market Outlook
9.7.1 South Korea Market Outlook by Value (COVID-19 Impact Recovery Analysis)
9.8 Australia Market Outlook
9.8.1 Australia Market Outlook by Value (COVID-19 Impact Recovery Analysis)
9.9 Rest of APAC Market Outlook
9.9.1 Rest of APAC Market Outlook by Value (COVID-19 Impact Recovery Analysis)
9.10 Asia-Pacific Market Outlook by Technology (COVID-19 Impact Recovery Analysis)
9.11 Asia-Pacific Market Outlook by Therapeutics Areas (COVID-19 Impact Recovery Analysis)
9.12 Asia-Pacific Market Outlook by Type (COVID-19 Impact Recovery Analysis)
9.13 Asia-Pacific Market Outlook by Product (COVID-19 Impact Recovery Analysis)

10 LAMEA Human Microbiome Therapeutics Market
10.1 LAMEA Market Overview
10.2 LAMEA Market Outlook by Value (COVID-19 Impact Recovery Analysis)
10.3 LAMEA Market Outlook by Country (COVID-19 Impact Recovery Analysis)
10.4 Brazil Market Outlook
10.4.1 Brazil Market Outlook by Value (COVID-19 Impact Recovery Analysis)
10.5 Saudi Arabia Market Outlook
10.5.1 Saudi Arabia Market Outlook by Value (COVID-19 Impact Recovery Analysis)
10.6 South Africa Market Outlook
10.6.1 South Africa Market Outlook by Value (COVID-19 Impact Recovery Analysis)
10.7 Mexico Market Outlook
10.7.1 Mexico Market Outlook by Value (COVID-19 Impact Recovery Analysis)
10.8 UAE Market Outlook
10.8.1 UAE Market Outlook by Value (COVID-19 Impact Recovery Analysis)
10.9 Rest od LAMEA Market Outlook
10.9.1 Rest of LAMEA Market Outlook by Value (COVID-19 Impact Recovery Analysis)
10.10 LAMEA Market Outlook by Technology (COVID-19 Impact Recovery Analysis)
10.11 LAMEA Market Outlook by Therapeutics Areas (COVID-19 Impact Recovery Analysis)
10.12 LAMEA Market Outlook by Type (COVID-19 Impact Recovery Analysis)
10.13 LAMEA Market Outlook by Product (COVID-19 Impact Recovery Analysis)

11 Competitive Landscape Analysis
11.1 Investment in Microbiome Therapeutics
11.2 Public Funding Initiatives
11.3 Private Funding Initiatives
11.3.1 Seventure Partners
11.3.2 Flagship Pioneering
11.4 Collaborations and Partnerships in the Global Market
11.5 Licensing and Manufacturing Agreements
11.6 Mergers and Acquisitions in the Global Market
11.7 Leading Market Players in Microbiome Therapeutics Market
11.8 Leading Market Players in Additive Microbiome Therapeutics Market
11.9 Leading Market Players in Modulatory Microbiome Therapeutics Market
11.10 Leading Market Players in Subtractive Microbiome Therapeutics Market

12 Global Human Microbiome Patent Analysis
12.1 Patent Overview
12.2 Patent Analysis
12.3 Patents by Year
12.4 Patents by Type
12.5 Patents by Disease Type
12.6 Patents by Company
12.7 Patents by Country
12.8 Patents by Assignee

13 Global Human Microbiome Clinical Trial Analysis
13.1 Clinical Trial Analysis by Disease Category
13.2 Share of Clinical Trials
13.3 Clinical Trial Analysis by Treatment Strategy
13.4 Share of Clinical Trials
13.5 Clinical Trial Analysis by Company
13.6 Share of Clinical Trials
13.7 Microbiome Therapeutics in Discovery and Preclinical Development
13.8 Microbiome Therapeutics Clinical Trials in Phase 3

14 Leading Company Profiles
14.1 AbbVie Inc. Company
14.1.1 Company Information
14.1.2 Company Overview
14.1.3 Company Financial Profile
14.1.4 Company Product Offerings
14.1.5 Company Recent Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Company Information
14.2.2 Company Overview
14.2.3 Company Financial Profile
14.2.4 Company Product Offerings
14.2.5 Company Recent Developments
14.3 Dow Inc. Chemical Company
14.3.1 Company Information
14.3.2 Company Overview
14.3.3 Company Financial Profile
14.3.4 Company Product Offerings
14.3.5 Company Recent Developments
14.4 Takeda Pharmaceuticals Company Ltd.
14.4.1 Company Information
14.4.2 Company Overview
14.4.3 Company Financial Profile
14.4.4 Company Product Offerings
14.4.5 Company Recent Developments
14.5 Johnson & Johnson Company
14.5.1 Company Information
14.5.2 Company Overview
14.5.3 Company Financial Profile
14.5.4 Company Product Offerings
14.5.5 Company Recent Developments
14.6 DuPont de Nemours, Inc Company
14.6.1 Company Information
14.6.2 Company Overview
14.6.3 Company Financial Profile
14.6.4 Company Product Offerings
14.6.5 Company Recent Developments
14.7 Merck & Co. Inc Company
14.7.1 Company Information
14.7.2 Company Overview
14.7.3 Company Financial Profile
14.7.4 Company Product Offerings
14.7.5 Company Recent Developments
14.8 Pfizer Inc. Company
14.8.1 Company Information
14.8.2 Company Overview
14.8.3 Company Financial Profile
14.8.4 Company Product Offerings
14.8.5 Company Recent Developments
14.9 Vertex Pharmaceuticals Company
14.9.1 Company Information
14.9.2 Company Overview
14.9.3 Company Financial Profile
14.9.4 Company Product Offerings
14.9.5 Company Recent Developments
14.10 Evelo Biosciences, Inc Company
14.10.1 Company Information
14.10.2 Company Overview
14.10.3 Company Financial Profile
14.10.4 Company Product Offerings
14.10.5 Company Recent Developments
14.11 Kaleido Biosciences Inc Company
14.11.1 Company Information
14.11.2 Company Overview
14.11.3 Company Financial Profile
14.11.4 Company Product Offerings
14.11.5 Company Recent Developments
14.12 Seres Therapeutics Inc Company
14.12.1 Company Information
14.12.2 Company Overview
14.12.3 Company Financial Profile
14.12.4 Company Product Offerings
14.12.5 Company Recent Developments
14.13 PureTech Health PLC Company
14.13.1 Company Information
14.13.2 Company Overview
14.13.3 Company Financial Profile
14.13.4 Company Product Offerings
14.13.5 Company Recent Developments
14.14 Nestle S.A. Company
14.14.1 Company Information
14.14.2 Company Overview
14.14.3 Company Financial Profile
14.14.4 Company Product Offerings
14.14.5 Company Recent Developments
14.15 Mayo Clinic Company
14.15.1 Company Information
14.15.2 Company Overview
14.15.3 Company Financial Profile
14.15.4 Company Product Offerings
14.15.5 Company Recent Developments
14.16 MaaT Pharma SA Company
14.16.1 Company Information
14.16.2 Company Overview
14.16.3 Company Financial Profile
14.16.4 Company Product Offerings
14.16.5 Company Recent Developments
14.17 4D Pharma Plc Company
14.17.1 Company Information
14.17.2 Company Overview
14.17.3 Company Financial Profile
14.17.4 Company Product Offerings
14.17.5 Company Recent Developments
14.18 Assembly Biosciences, Inc Company
14.18.1 Company Information
14.18.2 Company Overview
14.18.3 Company Financial Profile
14.18.4 Company Product Offerings
14.18.5 Company Recent Developments
14.19 F. Hoffmann-La Roche Ltd Company
14.19.1 Company Information
14.19.2 Company Overview
14.19.3 Company Financial Profile
14.19.4 Company Product Offerings
14.19.5 Company Recent Developments
14.20 Vedanta Biosciences Company
14.20.1 Company Information
14.20.2 Company Overview
14.20.3 Company Financial Profile
14.20.4 Company Product Offerings
14.20.5 Company Recent Developments

15 Conclusion & Recommendations

16 Glossary

List of Figures



Figure 1.1 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %)
Figure 3.1 Differences in Human Genome and Microbiome
Figure 3.2 Bacterial Distribution, by Body Site
Figure 3.3 Essential Functions of Human Microbiome
Figure 5.1 SWOT Analysis of Global Human Microbiome Therapeutics Market
Figure 6.1 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %)
Figure 6.2 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 6.3 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 6.4 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 6.5 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 6.6 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %)
Figure 6.7 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 6.8 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 6.9 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 6.10 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 6.11 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %)
Figure 6.12 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 6.13 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 6.14 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 6.15 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 6.16 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %)
Figure 6.17 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 6.18 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 6.19 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 6.20 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 6.21 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %)
Figure 6.22 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 6.23 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 6.24 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 6.25 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 6.26 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %)
Figure 6.27 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 6.28 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 6.29 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 6.30 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 7.1 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %)
Figure 7.2 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 7.3 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 7.4 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 7.5 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 7.6 North America Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %)
Figure 7.7 North America Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 7.8 North America Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 7.9 North America Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 7.10 North America Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 7.11 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %)
Figure 7.12 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 7.13 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 7.14 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 7.15 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 7.16 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %)
Figure 7.17 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 7.18 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 7.19 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 7.20 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 7.21 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %)
Figure 7.22 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 7.23 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 7.24 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 7.25 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 7.26 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %)
Figure 7.27 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 7.28 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 7.29 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 7.30 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 8.1 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %)
Figure 8.2 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 8.3 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 8.4 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 8.5 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 8.6 Europe Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %)
Figure 8.7 Europe Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 8.8 Europe Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 8.9 Europe Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 8.10 Europe Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 8.11 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %)
Figure 8.12 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 8.13 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 8.14 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 8.15 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 8.16 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %)
Figure 8.17 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 8.18 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 8.19 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 8.20 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 8.21 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %)
Figure 8.22 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 8.23 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 8.24 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 8.25 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 8.26 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %)
Figure 8.27 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 8.28 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 8.29 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 8.30 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 9.1 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %)
Figure 9.2 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 9.3 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 9.4 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 9.5 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 9.6 Asia-Pacific Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %)
Figure 9.7 Asia-Pacific Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 9.8 Asia-Pacific Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 9.9 Asia-Pacific Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 9.10 Asia-Pacific Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 9.11 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %)
Figure 9.12 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 9.13 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 9.14 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 9.15 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 9.16 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %)
Figure 9.17 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 9.18 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 9.19 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 9.20 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 9.21 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %)
Figure 9.22 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 9.23 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 9.24 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 9.25 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 9.26 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %)
Figure 9.27 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 9.28 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 9.29 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 9.30 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 10.1 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %)
Figure 10.2 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 10.3 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 10.4 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 10.5 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 10.6 LAMEA Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %)
Figure 10.7 LAMEA Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 10.8 LAMEA Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 10.9 LAMEA Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 10.10 LAMEA Human Microbiome Therapeutics Market by Country Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 10.11 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %)
Figure 10.12 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 10.13 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 10.14 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 10.15 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 10.16 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %)
Figure 10.17 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 10.18 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 10.19 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 10.20 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 10.21 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %)
Figure 10.22 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 10.23 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 10.24 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 10.25 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 10.26 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %)
Figure 10.27 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (V-Shaped recovery)
Figure 10.28 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (W-Shaped recovery)
Figure 10.29 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (U-Shaped recovery)
Figure 10.30 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %) (L-Shaped recovery)
Figure 14.1 AbbVie Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.2 AbbVie Inc: Company Operating Income 2015-2019 (US$Mn)
Figure 14.3 AbbVie Inc: Company EBITDA 2015-2019 (US$Mn)
Figure 14.4 AbbVie Inc: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.5 Bristol-Myers Squibb: Company Revenue 2015-2019 (US $Mn, AGR %)
Figure 14.6 Bristol-Myers Squibb: Company Operating Income 2015-2019 (US $Mn)
Figure 14.7 Bristol-Myers Squibb: Company EBITDA 2015-2019 (US $Mn)
Figure 14.8 Bristol-Myers Squibb: Company Net Income/Loss 2015-2019 (US $Mn)
Figure 14.9 Dow Inc Chemical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.10 Dow Inc Chemical: Company Operating Income 2015-2019 (US$Mn)
Figure 14.11 Dow Inc Chemical: Company EBITDA 2015-2019 (US$Mn)
Figure 14.12 Dow Inc Chemical: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.13 Takeda Pharmaceuticals: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.14 Takeda Pharmaceuticals: Company Operating Income 2015-2019 (US$Mn)
Figure 14.15 Takeda Pharmaceuticals: Company EBITDA 2015-2019 (US$Mn)
Figure 14.16 Takeda Pharmaceuticals: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.17 Johnson & Johnson: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.18 Johnson & Johnson: Company Operating Income 2015-2019 (US$Mn)
Figure 14.19 Johnson & Johnson: Company EBITDA 2015-2019 (US$Mn)
Figure 14.20 Johnson & Johnson: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.21 KKK: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.22 KKK: Company Operating Income 2015-2019 (US$Mn)
Figure 14.23 KKK: Company EBITDA 2015-2019 (US$Mn)
Figure 14.24 KKK: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.25 Merck & Co. Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.26 Merck & Co. Inc: Company Operating Income 2015-2019 (US$Mn)
Figure 14.27 Merck & Co. Inc: Company EBITDA 2015-2019 (US$Mn)
Figure 14.28 Merck & Co. Inc: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.29 Pfizer Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.30 Pfizer Inc: Company Operating Income 2015-2019 (US$Mn)
Figure 14.31 Pfizer Inc: Company EBITDA 2015-2019 (US$Mn)
Figure 14.32 Pfizer Inc: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.33 Vertex Pharmaceuticals: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.34 Vertex Pharmaceuticals: Company Operating Income 2015-2019 (US$Mn)
Figure 14.35 Vertex Pharmaceuticals: Company EBITDA 2015-2019 (US$Mn)
Figure 14.36 Vertex Pharmaceuticals: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.37 Evelo Biosciences, Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.38 Evelo Biosciences, Inc: Company Operating Income 2015-2019 (US$Mn)
Figure 14.39 Evelo Biosciences, Inc: Company EBITDA 2015-2019 (US$Mn)
Figure 14.40 Evelo Biosciences, Inc: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.41 Kaleido Biosciences, Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.42 Kaleido Biosciences, Inc: Company Operating Income 2015-2019 (US$Mn)
Figure 14.43 Kaleido Biosciences, Inc: Company EBITDA 2015-2019 (US$Mn)
Figure 14.44 Kaleido Biosciences, Inc: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.45 Seres Therapeutics, Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.46 Seres Therapeutics, Inc: Company Operating Income 2015-2019 (US$Mn)
Figure 14.47 Seres Therapeutics, Inc: Company EBITDA 2015-2019 (US$Mn)
Figure 14.48 Seres Therapeutics, Inc: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.49 PureTech Health Plc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.50 PureTech Health Plc: Company Operating Income 2015-2019 (US$Mn)
Figure 14.51 PureTech Health Plc: Company EBITDA 2015-2019 (US$Mn)
Figure 14.52 PureTech Health Plc: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.53 Nestle S.A.: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.54 Nestle S.A.: Company Operating Income 2015-2019 (US$Mn)
Figure 14.55 Nestle S.A.: Company EBITDA 2015-2019 (US$Mn)
Figure 14.56 Nestle S.A.: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.57 4D Pharma Plc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.58 4D Pharma Plc: Company Operating Income 2015-2019 (US$Mn)
Figure 14.59 4D Pharma Plc: Company EBITDA 2015-2019 (US$Mn)
Figure 14.60 4D Pharma Plc: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.61 Assembly Biosciences, Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 14.62 Assembly Biosciences, Inc: Company Operating Income 2015-2019 (US$Mn)
Figure 14.63 Assembly Biosciences, Inc: Company EBITDA 2015-2019 (US$Mn)
Figure 14.64 Assembly Biosciences, Inc: Company Net Income/Loss 2015-2019 (US$Mn)
Figure 14.65 F. Hoffmann-La Roche Ltd: Company Revenue 2015-2019 (US $Mn, AGR %)
Figure 14.66 F. Hoffmann-La Roche Ltd: Company Operating Income 2015-2019 (US $Mn)
Figure 14.67 F. Hoffmann-La Roche Ltd: Company EBITDA 2015-2019 (US $Mn)
Figure 14.68 F. Hoffmann-La Roche Ltd: Company Net Income/Loss 2015-2019 (US $Mn)

List of Tables



Table 1.1 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 2.1 Global Human Microbiome Therapeutics Market Summary Table
Table 3.1 Technologies for Microbiome Research
Table 3.2 Dysbiosis in Microbiome
Table 6.1 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 6.2 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 6.3 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 6.4 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 6.5 Global Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 6.6 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 6.7 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 6.8 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 6.9 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 6.10 Global Human Microbiome Therapeutics Market by Region Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 6.11 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 6.12 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 6.13 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 6.14 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 6.15 Global Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 6.16 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 6.17 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 6.18 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 6.19 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 6.20 Global Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 6.21 Modulatory Microbiome Therapeutics
Table 6.22 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 6.23 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 6.24 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 6.25 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 6.26 Global Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 6.27 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 6.28 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 6.29 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 6.30 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 6.31 Global Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 7.1 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 7.2 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 7.3 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 7.4 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 7.5 North America Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 7.6 US Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 7.7 US Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 7.8 US Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 7.9 US Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 7.10 US Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 7.11 Canada Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 7.12 Canada Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 7.13 Canada Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 7.14 Canada Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 7.15 Canada Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 7.16 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 7.17 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 7.18 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 7.19 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 7.20 North America Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 7.21 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 7.22 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 7.23 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 7.24 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 7.25 North America Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 7.26 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 7.27 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 7.28 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 7.29 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 7.30 North America Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 7.31 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 7.32 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 7.33 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 7.34 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 7.35 North America Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.1 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.2 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.3 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.4 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.5 Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.6 Russia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.7 Russia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.8 Russia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.9 Russia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.10 Russia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.11 Germany Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.12 Germany Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.13 Germany Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.14 Germany Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.15 Germany Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.16 UK Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.17 UK Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.18 UK Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.19 UK Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.20 UK Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.21 France Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.22 France Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.23 France Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.24 France Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.25 France Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.26 Italy Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.27 Italy Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.28 Italy Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.29 Italy Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.30 Italy Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.31 Rest of Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.32 Rest of Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.33 Rest of Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.34 Rest of Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.35 Rest of Europe Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.36 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.37 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.38 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.39 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.40 Europe Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.41 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.42 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.43 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.44 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.45 Europe Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.46 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.47 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.48 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.49 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.50 Europe Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 8.51 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 8.52 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 8.53 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 8.54 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 8.55 Europe Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.1 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.2 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.3 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.4 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.5 Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.6 Japan Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.7 Japan Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.8 Japan Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.9 Japan Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.10 Japan Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.11 China Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.12 China Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.13 China Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.14 China Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.15 China Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.16 India Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.17 India Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.18 India Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.19 India Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.20 India Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.21 South Korea Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.22 South Korea Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.23 South Korea Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.24 South Korea Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.25 South Korea Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.26 Australia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.27 Australia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.28 Australia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.29 Australia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.30 Australia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.31 Rest of Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.32 Rest of Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.33 Rest of Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.34 Rest of Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.35 Rest of Asia-Pacific Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.36 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.37 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.38 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.39 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.40 Asia-Pacific Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.41 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.42 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.43 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.44 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.45 Asia-Pacific Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.46 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.47 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.48 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.49 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.50 Asia-Pacific Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 9.51 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 9.52 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 9.53 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 9.54 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 9.55 Asia-Pacific Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.1 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.2 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.3 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.4 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.5 LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.6 Brazil Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.7 Brazil Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.8 Brazil Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.9 Brazil Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.10 Brazil Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.11 Saudi Arabia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.12 Saudi Arabia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.13 Saudi Arabia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.14 Saudi Arabia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.15 Saudi Arabia Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.16 South Africa Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.17 South Africa Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.18 South Africa Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.19 South Africa Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.20 South Africa Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.21 Mexico Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.22 Mexico Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.23 Mexico Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.24 Mexico Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.25 Mexico Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.26 UAE Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.27 UAE Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.28 UAE Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.29 UAE Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.30 UAE Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.31 Rest of LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.32 Rest of LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.33 Rest of LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.34 Rest of LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.35 Rest of LAMEA Human Microbiome Therapeutics Market by Value Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.36 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.37 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.38 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.39 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.40 LAMEA Human Microbiome Therapeutics Market by Technology Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.41 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.42 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.43 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.44 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.45 LAMEA Human Microbiome Therapeutics Market by Therapeutic Area Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.46 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.47 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.48 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.49 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.50 LAMEA Human Microbiome Therapeutics Market by Type Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 10.51 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %)
Table 10.52 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (V-Shaped recovery)
Table 10.53 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (W-Shaped recovery)
Table 10.54 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (U-Shaped recovery)
Table 10.55 LAMEA Human Microbiome Therapeutics Market by Product Forecast 2021-2031 (US$ million, AGR %, CAGR %) (L-Shaped recovery)
Table 11.1 Historical Funding Activity in Microbiome Therapeutics, 2015 and 2016
Table 11.2 Public Funding in Microbiome Therapeutics, 2018-August 2020
Table 11.3 Venture Funding in Microbiome Therapeutics, 2017-August 2020
Table 11.4 Collaborations and Partnerships in the Microbiome Therapeutics Market, 2017-August 2020
Table 11.5 Licensing and Manufacturing Agreements in the Microbiome Therapeutics Market, 2017-August 2020
Table 11.6 Leading Developers of Additive Microbiome Therapeutics, 2019
Table 11.7 Leading Developers of Modulatory Microbiome Therapeutics, 2019
Table 11.8 Leading Developers of Subtractive Microbiome Therapeutics, 2019
Table 12.1 Patents Issued for Microbiome Therapeutics, by Year, 2017-August 2020 (Number)
Table 12.2 Patents Issued for Microbiome Therapeutics, by Type, 2017- August 2020 (Number/%)
Table 12.3 Patents Issued for Microbiome Therapeutics, by Disease Type, 2017-August 2020 (Number/%)
Table 12.4 Patents Issued for Microbiome Therapeutics, by Company, 2017-August 2020 (Number)
Table 12.5 Patents Issued for Microbiome Therapeutics, by Country, 2017-August 2020 (Number/%)
Table 12.6 Patents Issued for Microbiome Therapeutics, by Assignee, 2017-August 2020 (Number/%)
Table 13.1 Clinical Trials in Microbiome Therapeutics, by Disease Type, August 2020 (Number)
Table 13.2 Share of Clinical Trials in Microbiome Therapeutics, by Disease Type, August 2020 (%)
Table 13.3 Clinical Trials in Microbiome Therapeutics, by Treatment Strategy
Table 13.4 Share of Clinical Trials in Microbiome Therapeutics, by Treatment Strategy (%)
Table 13.5 Clinical Trials in Microbiome Therapeutics, by Company
Table 13.6 Share of Clinical Trials in Microbiome Therapeutics, by Top 10 Companies (%)
Table 13.7 Microbiome Therapeutics in Discovery and Preclinical Development
Table 13.8 Microbiome Therapeutics Clinical Trials in Phase 3
Table 14.1 AbbVie Inc: Company Information
Table 14.2 AbbVie Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Table 14.3 AbbVie Inc: Company Product and Service Offerings
Table 14.4 AbbVie Inc: Company Product Pipeline
Table 14.5 AbbVie Inc: Company Recent Developments till Sept,2020
Table 14.6 Bristol-Myers Squibb: Company Information
Table 14.7 Bristol-Myers Squibb: Company Revenue 2015-2019 (US $Mn, AGR %)
Table 14.8 Bristol-Myers Squibb: Company Product and Service Offerings
Table 14.9 Bristol-Myers Squibb: Company Product Pipeline
Table 14.17 Takeda Pharmaceuticals: Company Product and Service Offerings